Elevance Sues Autism-Therapy Provider Over $160 Million in Alleged Fraud
ELV sits 55% above its 52-week low of $274.84.
Summary
Elevance sued Brooklyn-based autism-therapy provider Perfect Child in New York state court Wednesday, alleging it paid out $160 million on misleading claims over the last five years. The suit claims Perfect Child routed billing through more than 100 out-of-network LLCs, charging rates that at times exceeded $30,000 a day, and alleges fraud, breach of contract and conspiracy. Perfect Child's affiliates billed Elevance $800 million from 2021 through March 2026; Elevance denied many claims, including $102 million it flagged as duplicate bills, but still paid $160 million. The recovery, if any, is small next to Elevance's scale, but the case puts a number on alleged billing abuse at a time when medical cost trends are already pressuring margins — the Q3 10-Q showed a 27.5% drop in Health Benefits operating gain. The FBI is also investigating Perfect Child, per a Tuesday WSJ report, which raises the odds of broader industry scrutiny of autism-therapy billing.
At the time of this announcement, ELV was trading at $426.93 on NYSE in the Finance sector, with a market capitalization of approximately $92.2B. The 52-week trading range was $274.84 to $450.69. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.